TxGemma 27B
Open LLMs for drug discovery — 66 therapeutic tasks, Gemma 2-based.
About
TxGemma is a collection of lightweight open language models for therapeutics, released by Google in March 2025 in 2B, 9B, and 27B sizes based on the Gemma 2 family. Fine-tuned on the Therapeutics Data Commons, the models were validated across 66 therapeutic tasks spanning drug discovery and development, matching or beating best-in-class specialist models on 50 of 66 tasks. Chat variants mix therapeutic and general instruction data for conversational use, and starter Colabs cover inference, fine-tuning, and agentic workflows.
Limitations: explicitly a research model — Google notes it requires refinement and validation with research partners and regulators before any clinical-adjacent use. Best performance needs prompts formatted to the TDC structure, including SMILES strings and amino acid sequences where relevant.
Specs
Context window
Pricing
Free quota
API access
Weights
Released
Benchmarks
Provider-reported unless a source says otherwise. Benchmarks are marketing-adjacent by nature — treat them as directional.
Use cases
Trust score — 7/10
Scored 7/10 (metrics tier, metrics-v1). Evidence: Verified via vendor site/docs/GitHub and reputable coverage, wave 63; Trending score 68/100 from researcher assessment.